ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

NCI to Fund 122 More Grants in FY04

March 28, 2003

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012

President’s Cancer Panel Road Show Producers Ideas For Improving Finding Mechanisms; NCI Buys Some

July 23, 1982

House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations

August 3, 1979